Jubilant Pharmova Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve Unaudited standalone and consolidated financial results of the company for the quarter and half year ended September 30, 2026

October 30, 2026 BSE Limited National Stock Exchange of India Limited Floor 25, P. J. Towers Exchange Plaza Dalal Street, Fort Bandra Kurla Complex, Bandra (E) Mumbai - 400 001 Mumbai - 400 051 Scrip Code: 530019 Symbol: JUBLPHARMA Sub: Intimation of Board Meeting – November 13, 2026 Dear Sirs, In terms of Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the ‘Listing Regulations’), we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, November 13, 2026 to inter-alia consider the unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2026. The above mentioned document will be simultaneously posted on the Company's website at www.jubilantpharmova.com. This is for your information and record. Thanking you, Yours faithfully, For Jubilant Pharmova Limited Naresh Kapoor Company Secretary